Skip to main content

Multiple Myeloma Resource Center

Multiple Myeloma
Learning Library

New & Trending

Beth Finley-Oliver and Rachid Baz, Moffitt Cancer Center
Clinical Pearls
11/27/2023
Elizabeth Finley-Oliver, ARNP, MSN; Rachid Baz, MD
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN,...
11/27/2023
APP Institute Oncology
Lorinda Coombs
APP Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology

Clinical Pearls

APP Perspectives

Lorinda Coombs
APP Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology
Lorinda Coombs
APP Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology

Conference Coverage

Lorinda Coombs
APP Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology
Conference Coverage
04/10/2025
Janelle Bradley
A new study has identified both shared and distinct biological mechanisms underlying cancer-related cognitive impairment and anxiety in patients undergoing chemotherapy.
A new study has identified both shared and distinct biological mechanisms underlying cancer-related cognitive impairment and anxiety in patients undergoing chemotherapy.
A new study has identified both...
04/10/2025
APP Institute Oncology
Conference Coverage
04/10/2025
Janelle Bradley
Epigenetic analysis in postmenopausal women with early-stage breast cancer reveals distinct biological pathways—axonal guidance and synaptogenesis—underlying objective and subjective cognitive function, suggesting separate mechanisms driving...
Epigenetic analysis in postmenopausal women with early-stage breast cancer reveals distinct biological pathways—axonal guidance and synaptogenesis—underlying objective and subjective cognitive function, suggesting separate mechanisms driving...
Epigenetic analysis in...
04/10/2025
APP Institute Oncology
Conference Coverage
04/10/2025
Janelle Bradley
Study defines factors that shape rural cancer survivors’ use of symptom self-management strategies, including credibility, symptom severity, accessibility, personal preferences, and social support.
Study defines factors that shape rural cancer survivors’ use of symptom self-management strategies, including credibility, symptom severity, accessibility, personal preferences, and social support.
Study defines factors that shape...
04/10/2025
APP Institute Oncology
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP
Conference Coverage
11/27/2024
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, assesses the effect implementing an academic-community partnership has on doctor of nursing students who are interested in oncology.
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, assesses the effect implementing an academic-community partnership has on doctor of nursing students who are interested in oncology.
Christa Braun-Inglis, DNP, APRN,...
11/27/2024
APP Institute Oncology
Conference Coverage
11/21/2024
Gina Tomaine
Advanced practice providers play a unique role in delivering cancer screening services and follow-up care to vulnerable populations, emphasizing the importance of their expertise, accessibility, and patient-centered approach to improving...
Advanced practice providers play a unique role in delivering cancer screening services and follow-up care to vulnerable populations, emphasizing the importance of their expertise, accessibility, and patient-centered approach to improving...
Advanced practice providers play...
11/21/2024
APP Institute Oncology
Dylana Smith, MS, AGPCNP-BC, HNP
Conference Coverage
11/21/2024
Dylana Smith, MS, AGPCNP-BC, HNP, discusses an initiative to boost APP engagement at Memorial Sloan Kettering Cancer Center and the growth of the program since its inception.
Dylana Smith, MS, AGPCNP-BC, HNP, discusses an initiative to boost APP engagement at Memorial Sloan Kettering Cancer Center and the growth of the program since its inception.
Dylana Smith, MS, AGPCNP-BC,...
11/21/2024
APP Institute Oncology
Marlee Bogema, MSN, APRN, FNP-C
Conference Coverage
11/21/2024
Marlee Bogema, MSN, APRN, FNP-C, discusses a protocol developed by a community oncology practice which demonstrated that outpatient administration of bispecific antibodies is both safe and well-tolerated and reduces the number of required...
Marlee Bogema, MSN, APRN, FNP-C, discusses a protocol developed by a community oncology practice which demonstrated that outpatient administration of bispecific antibodies is both safe and well-tolerated and reduces the number of required...
Marlee Bogema, MSN, APRN, FNP-C,...
11/21/2024
APP Institute Oncology
Conference Coverage
11/20/2024
Stephanie Holland
According to second interim analysis results from the MARIPOSA-2 trial, amivantamab plus chemotherapy improved survival and post-progression outcomes compared to chemotherapy alone among patients with EGFR-mutated advanced non-small cell lung...
According to second interim analysis results from the MARIPOSA-2 trial, amivantamab plus chemotherapy improved survival and post-progression outcomes compared to chemotherapy alone among patients with EGFR-mutated advanced non-small cell lung...
According to second interim...
11/20/2024
APP Institute Oncology
Conference Coverage
11/20/2024
Allison Casey
According to the preplanned overall survival interim analysis from the phase 3 monarchE trial, abemaciclib plus endocrine therapy continues to show benefit for patients with HR-positive, HER2-negative high-risk early breast cancer.
According to the preplanned overall survival interim analysis from the phase 3 monarchE trial, abemaciclib plus endocrine therapy continues to show benefit for patients with HR-positive, HER2-negative high-risk early breast cancer.
According to the preplanned...
11/20/2024
APP Institute Oncology
Conference Coverage
11/18/2024
Allison Casey
Introduction of an IV push policy at an oncology urgent care clinic, led by an advanced practice provider, resulted in increased timely administration of antibiotics prior to hospitalization and a decrease in room dwell time.
Introduction of an IV push policy at an oncology urgent care clinic, led by an advanced practice provider, resulted in increased timely administration of antibiotics prior to hospitalization and a decrease in room dwell time.
Introduction of an IV push...
11/18/2024
APP Institute Oncology